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Abstract 
Background and objectives: Recent studies suggest that high homocysteine levels are associated with an 
increased risk of fractures. Homocysteine levels are known to be influenced by vitamin B12, vitamin D3 and 
folic acid status. Elevated plasma total homocysteine (tHcy) and deficiencies of folate and vitamin B12 are 
associated with risk of osteoporosis and bone loss. Therefore, this study aims to examine whether high 
plasma levels of homocysteine and low plasma levels of folate, vitamin B12 and vitamin D3 predicted a bad 
prognosis of bone health or not.  
Methods: A cross sectional study was conducted on (90) women whose ages were between (45–85 years 
old) in 2017–2018. Recorded information on T – score values were obtained from computerized DEXA 
machine at the Duhok Rheumatic disease and Rehabilitation center. Independent t – test by (SPSS version 
23) program was used to estimate relationship and risk assessment among study parameters comparing to 
levels of plasma total homocysteine (tHcy). 
Results: Hyperhomocysteinemia is associated with skeletal abnormalities and osteoporosis. We tested 
whether levels of homocysteine and critical co-enzymes of homocysteine metabolism, such as vitamin B12, 
D3 and folate which are related to bone mineral density (BMD) measured by DEXA. The current data 
demonstrates that homocysteine is highly significant (P value < 0.01) with each of age, waist 
circumferences (C. W.), vitamin B12, folic acid, vitamin D3 and T- score quartiles, also significant (P value 
< 0.05) with Body Mass Index (BMI), calcium (Ca+) and Total Body Fat percent (TBF %). 
Conclusions: Homocysteine seems to be a predictor for development of osteoporosis among study 
population (elderly menopaused women in Duhok city). The present data suggest a major association 
between folate, vitamin B12, vitamin D3 and bone mineralization. Our data documented the hypothesis that 
homocysteine may play a role in the pathogenesis of osteoporotic fractures. 
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Introduction 
Osteoporosis is an endless and multifactorial confusion that described via low bone 
mass and microarchitectural weakening of bones [1]. It has been recorded that the 
significant outcome of osteoporosis is bone fracture. Particularly hip fractures are as often 
as possible related with standardization and expanded mortality, and in this manner with 
an expanded social and monetary weight [2]. Deficiency of vitamin B12 and folic acid 
status as well as elevation of homocysteine concentration (more than 15𝜇mol/L) has been 
related in a few investigations with lower bone mineral density which resulted in 
increasing the incidence of bone fracture in elderly women [3]. The reason is due to a 
combination of natural and hereditary components, nutrition, lifestyle, and hormonal 
elements [4]. Vitamin B12 and folic acid are significant elements of homocysteine 
metabolism and regulating its plasma concentrations [5]. Hypothetically, switching raised 
concentrations of homocysteine via supplementation of folate and vitamin B12 could 
preserve the issue of hindered bone tissues healthiness [6]. 
Calcium and vitamin D3 play an important role in preservation and healthiness of 
bone tissues. In addition, it has been stated that around 50% of women that are under the 
treatment of osteoporosis have low level of Vitamin D3 as well as about 90% of women 
may not take sufficient amount of calcium. Recent studies have found out that recovery 
from osteoporotic disease is improved by a number of medications which lead to 
minimize the risk of bone fractures. The presence of adequate amount of Ca and Vitamin 
D3 in these medications will achieve this improvement [7]. 
Osteoporosis in menopaused women is mostly caused by estrogen inadequacy, 
while, natural and lifestyle factors as well as metabolic and hereditary clutters are 
contributing [8]. The World Health Organization has characterized osteoporosis as a Bone 
Mineral Density (BMD) which accounts more than 2.5 standard deviations (SD) beneath 
the mean for typical youthful women [8]. 
To summarize, osteoporosis is the most widely recognized type of the malady, 
influencing a large portion of the skeleton [9]. There are a wide range of kinds of 
osteoporosis. The most widely recognized type of osteoporosis is known as "essential 
osteoporosis", osteoporosis that is not caused by some other particular issue. Bone 
misfortune is caused by particular sicknesses or meds is alluded to as "optional 
osteoporosis." [10]. 
Materials and Methods 
Study design and study period 
The present cross-sectional study was conducted at the Duhok Rheumatic Disease 
and Rehabilitation Center, during the period of November 2017 until February 2018. 
The population enrolled in this Study  
The samples were collected randomly, previously prepared questioner was designed 
according to inclusion criteria, only (90) samples were selected from patients and asked to 
participate in this study project. The evaluation of osteoporosis level after taking Dual-
energy X-ray absorptiometry (DEXA) which is the gold standard method for diagnosis of 
osteoporosis in Rheumatoid Center in Duhok city. The respondents (osteoporotic women) 
were grouped into eight different classes on the basis of age, Waist circumferences (WC), 
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Body mass index (BMI), plasma levels of Vitamin D3, vitamin B12, Folic Acid, 
Homocysteine and quartiles of T-Score. 
Inclusion and Exclusion criteria: 
The inclusion criteria for the current study was as follow:  
Menopaused women aged 40 and above, Osteoporotic women with T – Score -2.5 and 
more and Patients not on study parameters medications particularly multivitamins 
containing vitamin B12, vitamin D3 and folic acid. While the Exclusion criteria for the 
present study was as follow: 
 Normal and osteopenic women. 
 Receiving of hormone replacement therapy. 
 Patients suffering from renal diseases. 
 Patients suffering from liver disorders. 
 Patients under the effect of chemotherapy. 
 Patients with type I and type II diabetes mellitus. 
 Patients on medication particularly multivitamins and antioxidants. 
 
Biochemical Analysis 
Measurement of Plasma total homocysteine (tHcy). 
Detection of Plasma total homocysteine (tHcy), folic acid, vitamin B12, vitamin D3 
and calcium using specific kits (Roche) according to company protocol instructions using 
Cobass 6000 autoanalyzer machine [11]. 
 
Test principle 
Homocysteine Enzymatic Assay is based on a novel enzyme cycling assay principle 
that assesses the co‑substrate conversion product instead of assessing co‑substrate or 
Hcy conversion products of Hcy, In this assay, oxidized Hcy is first reduced to free Hcy 
which then reacts with a co‑substrate, S‑adenosylmethionine (SAM), to form methionine 
(Met) and S‑adenosylhomocysteine (SAH), catalyzed by a Hcy S‑methyltransferase. 
SAH is assessed by coupled enzyme reactions where SAH is hydrolyzed into adenosine 
(Ado) and Hcy by SAH hydrolase, and Hcy is cycled into the Hcy conversion reaction to 
form a reaction cycle that amplifies the detection signal. The formed Ado is immediately 
hydrolyzed into inosine and ammonia. In the last step, the enzyme glutamate 
dehydrogenase (GLDH) catalyzes the reaction of ammonia with 2‑oxoglutarate and 
NADH to form NAD+. The concentration of Hcy in the sample is directly proportional to 
the amount of NADH converted to NAD+ (ΔA340 nm) [11]. 
Assay: 
Measuring mode Absorbance 
Abs. calculation mode Kinetic 
Reaction mode R1/R2-S-SR 
Reaction direction Decrease 
Wavelength A/B 340/659 nm 
Calc. first/last 50/62 
Unit µmol/L 
Journal of University of Babylon for Pure and Applied Sciences, Vol. (27), No. (6): 2019 
 
 
4 
 
Time required 
Each run we put 10 samples / 30 minutes. 
Statistical analysis 
Data was analyzed by using the Statistical Package for Social Sciences program 
(SPSS) version (23). T - test was used to compare between proportions. A    P value of ≤ 
0.05 was considered statistically significant, while P value was 0.01 it considered 
statistically as a highly significant. One Way ANOVA was used to compare among more 
than two groups. The Pearson correlation was used to determine the correlation 
coefficient between Homocysteine and study parameters. 
 
Results 
Demographic and laboratory characteristics of the study population are included in 
Table 1. 
Table (1) Frequency distribution of the study variables. 
Study variables N % 
Age (years) 
40-50 
51-60 
61-70 
>70 
 
18 
26 
32 
14 
 
20 
29 
36 
15 
BMI (kg/m2) 
Normal 
Overweight 
Obese 
 
9 
25 
56 
 
9.10 
25.28 
56.62 
WC (cm) 
Normal 
Abnormal 
 
17 
73 
 
88 
12 
T-Score 
(-2.5)-(-3.49) 
(-3.5)-(-4.49) 
(-4.5)-(-5) 
 
38 
21 
31 
 
45 
21 
34 
Homocysteine (µmol/L) 
Normal 
Abnormal 
 
15 
75 
 
14 
86 
Folic acid (ng/ml) 
Low 
Normal 
 
21 
69 
 
23 
77 
Vitamin B12 (pg/ml) 
Low 
Normal 
 
26 
64 
 
29 
71 
Vitamin D3 (ng/mL) 
Deficient 
Insufficient 
Sufficient 
 
13 
63 
14 
 
15 
69 
16 
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Homocysteine and study parameters 
It can be seen from table 2 that there was a definitely significant relationship between 
homocysteine and all study parameters.  
Table 2 Comparison of Demographics and Biochemical measurements in Normal 
Homocysteine & High Homocysteine Osteoporotic Women. 
 
Vitamin B12 and study variables 
Regarding vitamin B12, table 3 shows that there was a highly significant 
differences in vitamin B12, age, vitamin D3, homocysteine and T – score (P < 0.01). 
Table 3 Comparison of Demographics and Biochemical measurements in Normal 
Vitamin B12 & Low Vitamin B12 of Osteoporotic Women 
 
Study variable 
Mean & SD of Osteoporotic 
Women with Normal 
Vitamin B12 
(n = 64) 
Mean & SD of 
Osteoporotic Women 
with Low Vitamin B12 
(n = 26) 
 
P-value 
Age 55.78 ± 7.85 69.80 ± 7.26 < 0.01 
Waist circumferences (cm) 105.32 ± 13.80 110.19 ± 15.51 NS 
Body mass index (Kg/m2) 32.42 ± 5.34 33.41 ± 6.66 NS 
Vitamin D3 (ng / ml) 22.13 ± 7.35 15.42 ± 10.03 < 0.01 
Folic acid (ng / ml) 8.29 ± 4.14 1.85 ± .46 < 0.01 
Homocysteine (µ mol /L) 17.24 ± 2.64 24.18 ± 2.54 < 0.01 
T – Score -3.44 ± .72 -4.59 ± .24 < 0.01 
Total Body Fat (TBF) (%) 42.54 ± 8.71 43.97 ± 9.50 NS 
 
Study variables 
Mean & SD of 
Osteoporotic Women 
with Normal 
Homocysteine 
(n = 15) 
Mean & SD of 
Osteoporotic Women 
with High 
Homocysteine 
(n = 75) 
 
P-value 
Age 49.86 ± 8.16 61.82 ± 9.09 < 0.01 
Waist circumferences (cm) 98.13 ± 12.41 108.45 ± 14.22 < 0.01 
Body mass index (Kg/m2) 31.03 ± 4.98 33.04 ± 5.85 < 0.05 
Vitamin D3 (ng / ml) 25.71 ± 6.82 19.09 ± 8.66 < 0.05 
Vitamin B12 (pg / ml) 663.87 ± 151.83 312.06 ± 152.21 < 0.01 
Folic acid (ng / ml) 12.27 ± 3.72 5.26 ± 3.76 < 0.01 
T – Score -2.84 ± .56 -3.96 ± .73 < 0.01 
Total Body Fat (TBF) (%) 40.52 ± 8.79 43.44 ± 8.92 < 0.05 
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Folic acid and study variables 
Regarding folic acid, there was a highly significant relation in age, vitamin D3, 
homocysteine vitamin B12, T – score and waist circumferences (P < 0.01). 
Table 4 demonstrate the Comparison of Demographics and Biochemical 
measurements in normal folic acid and low folic acid of osteoporotic women. 
 
 
Study variables 
Mean & SD of Osteoporotic 
Women with Normal 
Folic acid 
(n = 69) 
Mean & SD of 
Osteoporotic Women 
with Low Folic acid 
(n = 21) 
 
P-value 
Age 56.95 ± 8.78 69.28 ± 7.56 < 0.01 
Waist circumferences (cm) 104.56 ± 13.77 113.85 ± 14.43 < 0.05 
Body mass index (Kg/m2) 32.08 ± 5.20 34.76 ± 6.98 NS 
Vitamin D3 (ng / ml) 23.60 ± 11.88 13.37 ± 8.45 < 0.01 
Vitamin B12 (ng / ml) 431.29 ± 191.33 171.57 ± 21.12 < 0.01 
Homocysteine (µ mol /L) 17.51 ± 2.72 24.93 ± 2.24 < 0.01 
T – Score -3.51 ± .75 -4.63 ± .18 < 0.01 
Total Body Fat (TBF) (%) 42.31 ± 8.79 45.06 ± 9.20 NS 
 
Vitamin D3 and study parameters 
Regarding vitamin D3 as shown in table 5, there was a highly significant 
differences among sufficient and insufficient vitamin D3 with each of waist 
circumference, body mass index and total body fat. In addition, as shown in table 5, it can 
be seen that there was a highly significant difference among sufficient and deficient 
vitamin D3 and all study parameters except serum calcium. Finally, taking all together, 
there was a highly significant relationship between vitamin D3 and all study parameters 
except serum calcium, vitamin B12 and folic acid. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Journal of University of Babylon for Pure and Applied Sciences, Vol. (27), No. (6): 2019 
 
 
7 
 
Table 5: One-way ANOVA analysis comparison of demographics and biochemical 
measurements in sufficient vitamin D3, insufficient vitamin D3 and deficient vitamin 
D3 of osteoporotic women. 
 
 
Correlation analysis: 
According to Pearson correlation coefficient (r). Homocysteine (µ mol /L) in study 
sample was highly significant correlations between all study variables including age in 
years, body mass index (Kg/m2), waist circumferences (cm), vitamin D3 (ng / ml), Folic 
acid (ng / ml), vitamin B12 (pg / ml), homocysteine (µ mol /L), T - Score and Total Body 
Fat (TBF %), table (6). 
Table 6: Correlation between homocysteine (µ mol /L) and other related parameters 
in osteoporotic women. 
Variables (r) P-value 
Age .745 < 0.01 
Body mass index (Kg/m2) .281 < 0.01 
Waist circumferences (cm) .376 < 0.01 
Vitamin B12 (pg / ml) -.832 < 0.01 
Folic acid (ng / ml) -.851 < 0.01 
Vitamin D3 (ng / ml) -.557 < 0.01 
T – Score -.847 < 0.01 
Total Body Fat (TBF) (%) .255 < 0.05 
 
Folic acid (ng / ml) in osteoporotic women was highly significant correlations between 
age in years, waist circumferences (cm), vitamin D3 (ng / ml), vitamin B12 (pg / ml), 
homocysteine (µ mol /L) and T – Score table (7) and there was significant correlation 
 
Study variables 
Mean & SD of 
Osteoporotic Women 
with Sufficient 
Vitamin D3 
(n = 14) 
Mean & SD of 
Osteoporotic Women 
with Insufficient 
Vitamin D3 
(n = 63) 
Mean & SD of 
Osteoporotic 
Women with 
Deficient Vitamin 
D3 
(n = 13) 
 
P-value 
Age 58.07 ± 13.36 57.85 ± 8.19 70.35 ± 6.72 < 0.01 
Waist circumferences 
(cm) 
93.14 ± 7.67 109.64 ± 12.71 107.42 ± 19.04 < 0.01 
Body mass index (Kg/m2) 27.17 ± 3.15 33.94 ± 5.48 32.76 ± 5.84 < 0.01 
Vitamin B12 (ng / ml) 440.58 ± 224.97 388.10 ± 198.86 223.69 ± 97.77 NS 
Folic acid (ng / ml) 8.43 ± 4.69 6.68 ± 4.60 3.31 ± 2.52 NS 
Homocysteine (µ mol /L) 17.20 ± 3.92 18.83 ± 3.64 23.10 ± 3.99 < 0.01 
T – Score -3.42 ± .90 -3.69 ± .76 -4.48 ± .54 < 0.01 
Total Body Fat (TBF) (%) 32.57 ± 6.27 45.17 ± 8.11 43.53 ± 7.50 < 0.01 
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with body mass index (Kg/m2). But folic acid (ng / ml) in osteoporotic women group was 
non-significant only Total Body Fat (TBF %). 
 
Table 7: Correlation between folic acid (ng / ml) and other related parameters in 
study patients. 
Variables (r) P-value 
Age -.600 < 0.01 
Body mass index (Kg/m2) -.264 < 0.05 
Waist circumferences (cm) -.363 < 0.01 
Vitamin B12 (pg / ml) .775 < 0.01 
Vitamin D3 (ng / ml) .433 < 0.01 
Homocysteine (µ mol /L) -.851 < 0.01 
T – Score .811 < 0.01 
Total Body Fat (TBF) (%) -.204 NS 
 
Vitamin B12 (pg / ml) in osteoporotic women was highly significant correlations 
between age, waist circumferences (cm), vitamin D3 (ng / ml), folic acid (ng / ml), 
homocysteine (µ mol /L) and T - Score table (8). However, vitamin B12 (pg / ml) in 
osteoporotic women group was non-significant with body mass index (Kg/m2) and Total 
Body Fat (TBF %). 
 
Table 8: Correlation between vitamin B12 (pg / ml) and other related parameters in 
osteoporotic women. 
Variables (r) P-value 
Age -.693 < 0.01 
Body mass index (Kg/m2) -.183 NS 
Waist circumferences (cm) -.342 < 0.01 
Folic acid (ng / ml) .775 < 0.01 
Vitamin D3 (ng / ml) .461 < 0.01 
Homocysteine (µ mol /L) -.832 < 0.01 
T – Score .816 < 0.01 
Total Body Fat (TBF) (%) -.182 NS 
 
Discussions 
Overview 
Recent epidemiological researches demonstrated that bone diseases and bone losses 
closely associated with prominent elevation of Homocysteine level in blood known as 
Hyperhomocysteinemia [12]. This increase in homocysteine concentration resulted in 
disruption in its metabolism, however, homocysteine metabolism is mainly controlled by 
folate and vitamin B12 [13]. furthermore, when there is defect in the action of 
methylenetetrahydrofolate (MTHFR) reductase enzyme. In fasting conditions Mild 
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hyperhomocysteinemia might be observed due to the mild impairment in the methylation 
pathway (i.e. inadequate amount of each of vitamin B12 and folic acid or (MTHFR) 
defect) [14]. 
Studies have demonstrated that Hyperhomocysteinemia (> 15 mmol/L) raise the 
activity of osteoclast and remodeling of bones. Furthermore, this will lead to an increase 
the impact of homocysteine on development of bones [15]. Kang and Trelstad (1972) 
discovered that homocysteine interfered with collagen cross-linking from filtered rodent 
skin collagen, However, high concentration of homocysteine represses the action of lysyl 
oxidase (a catalyst associated with cross- linking of collagen) and in this manner animate 
osteoclast action in lifted fixation. 
The present study demonstrates that high levels of serum Homocysteine were 
positively correlate and highly significant (P value < 0.01) with plasma vitamin B12, 
vitamin D3 and folic acid concentrations. This clarify that in the present study plasma 
homocysteine might have a direct impact in the pathogenesis of osteoporosis and other 
related bone diseases which lead to pathological fractures in elderly persons and might be 
considered as a predisposing factor for bone loss. 
The data from present study shows that plasma level of homocysteine is closely 
related to plasma levels of vitamin B12, vitamin D3 and folic acid. Furthermore, the 
current data clarifies that Homocysteine is highly significant (P value < 0.01) with each 
of age, waist circumferences (CW), vitamin B12, folic acid, vitamin D3 and T- score 
quartiles and significant (P value < 0.05) with BMI (Body Mass Index) and total body fat 
percent (TBF %) on the other hand, Homocysteine were also positively corelated with 
each of age, BMI, TBF, WC,  T – score quartiles. 
Plasma Homocysteine and Age 
The ages of menopaused women who have participated in the current study whose 
ages were between (40 – 85 years old). Homocysteine was positively correlated with age 
(table 3.6) meaning that the homocysteine level increased by the age. The 
Hyperhomocysteinemia in elderly women will affect on bone mineralization and 
remodeling by elimination of calcium and minerals from the bone as well as bone 
fragility and then fracturing [16]. Aging progress will decrease body response to many 
nutrient factors, which might have a great role to keep body minerals in balance, for 
instance, decrease in the activation of vitamin D3 in kidneys in elderly ( after exposing 
the subcutaneous fat to the sun light, final activation of vitamin D3 will take place in 
kidneys)  due to elderly age as a result of decreased renal response to parathyroid 
hormone and inadequate absorption of calcium from the intestinal tract. However, elderly 
women will need sufficient amount of PTH to stimulate vitamin D3 activation and 
production. Cholecalciferol play an essential role in the pathogenesis of osteoporosis, so 
it’s decrease will have a negative effect on bone texture and development of senile 
osteoporosis. A Systematic Review with Meta-Analyses done by van Wijngaarden J. P. et 
al 2012 shows a strong relationship between bone loss (osteoporosis) T – score > -2.5 and 
age. Similar results were recorded in the current study as shown in tables (3.14 and 3.15). 
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Plasma Homocysteine and Obesity Parameters 
Previously, it has been stated that diseases of bones (bone loss) and obesity are two 
irrelevant illnesses, nowadays there are several researches demonstrated that obesity and 
bone diseases are closely related to each other and both share many predisposing factors 
[17]. For instance, environmental and genetic factors. Body weight composed of body 
fluids, soft tissues and hard tissues, fat (which is a component of soft tissues) is regarded 
as the main component of body weight, after maturity only body fat is changeable (either 
by exercise or by food regimen). Recent studies demonstrated that total body fat which is 
the most prominent guides of obesity, may have a beneficial effect on bone health. The 
assimilation and differentiation of osteoblast and adipocyte is created as a result of the 
maturation of common precursor stem cells. Furthermore, production of hormones which 
have a direct and great effect on bone health known as adipocyte – derived hormones 
[18]. 
- Waist circumferences 
Taking waist circumferences as a marker for obesity in patients with osteoporosis and 
studying serum homocysteine in those patients has been conducted by several studies. All 
of them concluded that W. C. was closely correlated with bone loss [19]. Similarly, our 
data also demonstrated that hyperhomocysteinemia was significantly seen in patients with 
high W. C. Al- Bayyari N. et al. (2017) conclude that in overweight women elevation of 
plasma homocysteine concentration is prominently seen in women with abnormal WC 
measurement, and it might be regarded as independent predictor of plasma homocysteine 
level [19].  
- Body mass index (BMI) 
In present study, the obese and overweight patients (women) with osteoporosis 
whose T – score was (> -2.5), were documented by DEXA machine had high values of 
plasma homocysteine (> 15 mmol / L) could be seen. Study conducted by Carranza-Lira 
S. et al. (2002) and Asomaning K. et al. (2006) Summarized that overweight and obese 
women with high BMI (> 25 Kg / m2) are at increased risk of osteoporosis [20]. 
- Total Body Fat (TBF %):  
Similarly, W.C. and BMI the TBF also were positively corelated with homocysteine 
concentration. This concludes that the current study concluded that the Obesity 
parameters (WC, BMI and TBF) have effect on homocysteine level in positive manner as 
shown in (Table 3.6). Several studies concluded that adipose tissue (body fat) is not 
functionless body constituent, furthermore, it is responsible for production and secretion 
of several biologically active substances, for example, resistin, estrogen hormone, 
adiponectin and interleukin – 6 (IL-6). These substances either directly or indirectly play 
an important and effective role as a source of energy, also play a great role in bone health 
and body metabolisms. On the other hand, many endocrine organs also have a great role 
in bone health, for instance, the pancreas which produce molecules called bone – active 
substances such as amylin and insulin. The action and effect of such molecules 
throughout the body including bone may interpret the relationship between bones and 
body fat [21]. Finally, osteoblast and adipocyte originate from the same source of cells 
known pluripotential mesenchymal stem cells. Normally, this stem cells equally 
differentiated into both osteoblasts and adipocytes, however, this differentiation is under 
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control and regulated by many interacting mechanisms and pathways which may 
participate to the final effect of body fat on body bones. Some enzymes indirectly play a 
role in bone homeostasis, for example, aromatase enzyme, which presents in adipose 
tissue and gonads. This enzyme is responsible for the synthesis of estrogen hormone by 
using testosterone or androstene, as well as estrogen have a great role in bone health and 
protect bones against osteoporosis by make an inhibition to osteoclast action and bone 
resorption, and at the same time make a stimulation to osteoblast cells which have a great 
role in bone remodeling. In this case the elderly women (postmenopausal women) are 
lack to estrogen hormone as a result of the absence of menstrual cycle as well as the 
ovaries no longer produces estrogen, so extragonadal estrogen which is mainly produced 
from adipose tissue and become the main source of estrogen and may compensate the 
stopped estrogen from the workout ovaries [22]. 
Therefore, in obese postmenopausal women a high amount of body fat suggested to 
have a protective role on bones because of elevation in production of extragonadal 
estrogen which will have a potential effect on preserving bones from losses. In 
postmenopausal women (elderly women) any decrease in estrogen level will cause an 
increase in central body fat as well as increase chance of bone turnover and then bone loss 
will be accelerated. Furthermore, recent studies show that declining in endogenous 
estrogen level in elderly women complimented by declining in osteoblasts numbers and 
elevation in adipocyte counts. For that reason, in postmenopausal women estrogen 
replacement therapies will prevent or reduces menopause – induced fat gains and 
decreases the occurrence early postmenopausal osteoporosis. To sum up, the incompatible 
relationship between total body fat percent (TBF %), body mass index (BMI) and total 
plasma homocysteine (tHcy) have been reported in the general population. The present 
research reviewed the hypothesis that increased plasma level of homocysteine are closely 
associated with increased W.C.  levels, overweight and obese women with BMI (25 – 
29.9 Kg / m2) (more than 30 Kg / m2) respectively and total body fat percent elevation. 
In Duhok City, obesity and overweight are prevalent among elderly women and 
hyperhomocysteinemia, along with obesity and overweight, are independent risk factors 
for osteoporosis.  
Plasma Homocysteine and Nutritional factors 
Some reports illustrate the relationship between raised plasma homocysteine and 
fracture threats, while others discover no relationship. Nonetheless, it is not an evident 
whether this is identified with aggregate homocysteine or not, or the measurement of 
vitamin D3, vitamin B12 and folic acid, which act as a co-enzyme for homocysteine 
metabolism (re-methylation of homocysteine to methionine), or to different reasons for 
raised aggregate homocysteine [23]. for example, ecological elements or fundamental 
sickness. Holstein et al. (2011) pointed out that hyperhomocysteinemia and S-
adenosylhomocysteine have an effect on bone health. Additionally, a low limit of 
methylation, apprehension of morphology in diminished bone among peoples. These 
nutritional elements interpret that there is a relationship between the modified bone 
morphology and plasma level of homocysteine and S-adenosylhomocysteine. At present, 
there are limited investigations intended to assess the impact of vitamin B12, folate and 
vitamin D3 on bringing down plasma homocysteine level toward normal and the 
consequences for bone comfort.  
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Vitamin D3 and Bones  
The process of bone mineralization is an important natural mechanism to keep 
bones safe. There are many physiological factors either directly or indirectly affect such 
process even positively or negatively. Vitamin D3 (1,25 OH2D), the active form of 
vitamin D3) is regarded as one of a major substance that keep bone homeostasis, any 
deficiency in vitamin D3 level will cause bone deformities and bone diseases, for 
example, osteomalacia, bone loss and development of osteoporosis and bone fractures 
(particularly in elderly women) [24]. 
Studies demonstrated that vitamin D3 has a multi effect on bones. The direct role of 
this vitamin on bones is very complicated process, because it acts directly on certain cell 
types which are the main bone constituents, for instances, osteoclast, osteoblast and bone 
stromal cells. There is a direct relationship between vitamin D3 and parathyroid hormone 
(PTH). Formerly, scientists concluded that vitamin D3 play a role in resorption of bones 
because of its action on bones through stimulation and differentiation of certain cell types 
named precursor cells. This is a mononuclear phagocyte of macrophage lineage to be 
combined with osteoclasts cells (multinucleated and mature cells). Studies concluded that 
vitamin D3 contribute in the process of early stage of osteoclast production which is 
called osteoclastogenesis, through which vitamin D3 directly acts on osteoclast precursor 
cells, which compromises a complex interaction among cells like bone stromal cells, 
osteoblasts and osteoclast precursor cells [25]. In the late step of the differentiation 
protocol, the produced osteoclasts will loss its VDR, and then vitamin D3 indirectly 
promotes the differentiation by acting on cells in osteoblast lineage. Perhaps, osteoblast 
stromal cells will induce osteoclast differentiating – inducing substances. 
The present study will show the great relation between both Homocysteine and vitamin 
D3. Sufficient vitamin D3 will affect negatively on Homocysteine levels as well as good 
bone health and vice versa as shown in (Table 3.11). Similar results were obtained by 
Yuefeng Zho et al (2016), in which patients with elevated homocysteine had deficient to 
vitamin D3 [25]. 
Effect of vitamin B complexes on bones 
Generally, vitamin B complexes have a great effect in bone preservation 
particularly vitamin B12. The present study illustrates the positive relationship between 
this type of B vitamin and homocysteine as shown in table (3.7). The Rotterdam study 
(2007) believed that bone mineral density (BMD) is associated with osteoporosis. Linking 
of the collagen to the bone matrix will affect by the circulating homocysteine 
concentration. However, elevated homocysteine concentration will cause an alteration in 
bone matrix and resulting fragile bones. Alteration in collagen cross linking will not 
affect bone mineral density (BMD), therefor, the findings are bone fractures rather than 
bone mineral density alteration as concluded by van Meurs et . al (2004). 
Several researches hypothesized the great effect of B vitamins on bones particularly 
vitamin B12 as well as its deficiency will cause weaken the maturation process of 
osteoblast cells. Scientists hypothesized that alkaline phosphatase activity and 
proliferation of osteoblasts are under control of circulating vitamin B12 concentration, 
while on the other hand, Herrmann et. Al. (2007) was unable to demonstrate any reliable 
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and significant association between osteoblast activity and circulating folate and vitamin 
B12 concentrations. Recently, studies suggested that high circulating homocysteine 
concentration and low concentration of vitamin B12 will make stimulation to osteoclast 
activity as well as bone fragility. In spite of folate and vitamin B12, there are another B 
complex vitamin like vitamin B6 (pyridoxine), micronutrients and choline contribute in 
homocysteine metabolism as well as affecting plasma homocysteine level and 
subsequently affect bone health. Because of folic acid and vitamin B12 are the most 
common substances interfering plasma homocysteine level, therefore, both are regarded 
as homocysteine – lowering agents. 
The impact of folic acid on bones  
Folic acid plays a great role in bone health. This will contribute in homocysteine 
remethylating process to methionine. The present research demonstrates a significant 
association between folic acid and homocysteine as shown in (Table 3.8). The Hordaland 
homocysteine study (2007) illustrates that folic acid has been connected to bone mineral 
density and a reduced fracture, in addition, homocysteine is an indicator for hip fracture 
among elderly people. Folate was an indicator among women, however there is restricted 
proof to help a direct unthinking impact of folate on bone [26]. 
Homocysteine as a marker in Osteoporotic patients (T – Score Quartiles) 
The degrees of osteoporosis are varies depending on the T – score value. The 
degree of osteoporosis was documented by DEXA machine (the gold standard method for 
diagnosing osteoporosis). According to WHO criteria, osteoporosis is classified into three 
groups (Mild = -2.5 ~ -3.4, Severe = -3.5 ~ -4.4, Severe with fracture = < -4.5). In the 
present study, homocysteine was highly significant (p value = > 0.01) with T – score 
quartiles as showed in (table 3.14) [27]. 
Statistically the correlation between homocysteine and all study parameters (Age, 
waist circumferences, body mass index, vitamin D3, folic acid, vitamin B12, calcium, T 
score and total body fat) are highly significant (p value > 0.01) as shown in table (3.19). 
This correlation means that overweight  elderly women with insufficient vitamin D3 
(insufficient exposure to sun light or inadequate gaining dietary vitamin D3) also 
deficiency of each of folic acid and vitamin B12 (less than 2 ng / ml and less than 199.9 
pg / ml respectively) are more susceptible to elevation of homocysteine level as well as 
development of osteoporosis, because folic acid and vitamin B12 have a great role in 
homocysteine metabolism and recycling back to methionine [27].  
 
 
Conclusions 
According to the findings of the present study the researcher concluded that: 
➢  The study showed that the majority of the study participants were elderly women and 
all of them were menopaused, most of them were obese and overweight with 
abnormal waist circumference accompanied high percent of total body fat 
(TBF). 
➢  Plasma levels of vitamin D3, vitamin B12 and folate were low in patients with 
osteoporosis. 
➢  Plasma Homocysteine were significantly high in patients with Osteoporosis. This 
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was seen particularly in patients with high T  –  Score values. 
➢  The current study concluded that the majority of the osteoporotic group have high 
Homocysteine level with very low T – scour values. 
➢  High body mass index (BMI) and waist circumferences (WC), and low vitamin B12, 
folate and vitamin D3 levels showed high homocysteine levels with low T– scour 
values. 
➢  There were significant association between age, vitamin status, total body fat or BMI 
and T – scour values and total plasma homocysteine. 
➢  Finally, the present study conclude that total plasma homocysteine is positively 
correlated with age, plasma levels of vitamins (folic acid, vitamin B12 and vitamin 
D3), body mass index and also clearly correlated with menopaused status.  
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 الخلاصة
مباشرة بزيادة نسبة خطر : الدراسات الحديثة تشير الى انه المستويات العالية للحامض الاميني هوموسيستين له علاقة الخلفية والاهداف
الحمض الاميني  الدى المسنين خاصة النساء (بعد سن اليأس). و تشير ايضا ان مستوى هذ تنخر العظام التي تؤدي الی الکسورالاصابة ب
دم وكذلك و حامض الفوليك. زيادة نسبة الهوموسيستين في بلازما ال 3, فيتامين دي 21مرتبط بشكل اساسي بمستويات كل من فيتامين بي 
يشير الى زيادة احتمالية حدوث هشاشة وفقدان  3و فيتامين دي  21انخفاض ملحوظ في مستويات كل من حامض الفوليك, فيتامين بي 
قوام العظام. لذلك, تهدف هذه الدراسة الى تحديد مستوى الهوموسيستين في الدم, ففي حالة زيادة نسبة الهوموسيستين عن الحد الطبيعي 
تتنبأ بسوء تشخيص حالة العظام و  3و فيتامين دي 21) وانخفاض مستوى كل من حامض الفوليك, فيتامين بي L/lom𝜇 51(أکثر من 
 هشاشته وبالتالي الکسور.
. تم استخدام جهاز 8102 – 7102) سنة في عامي 58 – 54) امرأة تتراوح أعمارهن بين (09: اجريت دراسة مقطعية على (طريقة العمل
سكور) المسجلة من حاسبة الجهاز الموجود في مركز دهوك للامراض الروماتيزمية  –حصول على المعلومات حول قيمة (تي (ديكسا) لل
) لغرض الحصول على أنه هل هناك علاقة 32واعادة التأهيل الطبي.في هذه الدراسة تم استخدام برنامج (اس بي اس اس ) الاصدار رقم (
 ن في بلازما الدم و معاملات الدراسة الاخرى.أحصائية بين اجمالي الهوموسيستي
هذه الدراسة اختبرنا ما إذا كانت مستويات ستين في الدم بتشوهات الهيكل العظمي وهشاشة في العظام. في ي: يرتبط فرط الهوموسالنتائج
يك التي لهم علاقة بكثافة المعادن و حامض الفول 3و فيتامين دي  21الهوموسيستين والإنزيمات الحرجة في عملية أيضه مثل فيتامين بي 
في العظام التي تقاس بجهاز ديكسا للمرضى (بعد انقطاع الطمث) المشاركين في هذا البحث. تم الوصول الى النتائج على انه 
 3, وفيتامين دي 21) وثيقة مع كل من العمر, قياس الخصر, حامض الفوليك, فيتامين بي 100.0اقل من  pالهمومسيستين على علاقة ( 
) مع كل من كالسيوم الدم, مؤشر كتلة الجسم و 500.0اقل من  p و أيظا له علاقة مع كل من ( سكور) –و كذلك مع مجاميع (تي 
 اجمالي الدهون في الجسم.
ستين هو مؤّشر على تطور مرض هشاشة العظام بين مجتمع الدراسة (النساء المسنات في يالاميني الهوموس: يبدو أن الحمض الاستنتاجات
و حامض الفوليك وتمعدن العظام. توثق  3, فيتامين دي 21مدينة دهوك). البيانات الحالية تشير إلى وجود علاقة كبيرة بين فيتامين بي 
 ني الهوموسيستين قد يلعب دوًرا في التسبب في تطور حالة هشاشة العظام وكسورها.بياناتنا الفرضية القائلة بأن الحمض الامي
